Gene therapy is the insertion of genes into cells to change or normalize defective genetic material.
Detailed description
Target cells are somatic cells, which are cells that are not part of the germ line. Therefore, induced changes are not inheritable. Cells are removed, treated and transferred back. Another option is to treat the cells within the body. To do so, the functional gene or a “gene scissor” to repair a defective gene is introduced into the cells. Despite first successes, gene therapy is still in its infancy.
More about “Gene therapy”
Please use this image only in connection with the current press release.
The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time
The clock is ticking: The motto of this year's World Tuberculosis Day makes clear that tuberculosis still remains one of the world's deadliest infections. In particular, people in poorer countries are
Please use this image only in connection with this press release.
The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that
Please use this image only in connection with this press release.
The treatment of tuberculosis (TB) is long, demanding, and expensive. In particular, the ever increasing emergence of resistant tuberculosis bacteria requires a lot of patience: In these cases, the
The development of potent antiretroviral treatment (ART) strategies has significantly changed the face of the HIV/AIDS pandemic from a lethal disease to a chronic livable condition for infected individuals with access to care. However, in spite of ground-breaking advances in anti-HIV treatment, cure ...
Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer
The Munich DZIF team led by Prof. Ulrike Protzer is developing a novel therapeutic approach to cure chronic hepatitis B. Researchers at Helmholtz Munich and Technical University of Munich (TUM) found
